ロード中…
Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
Background: Doxorubicin (DOX), a broad-spectrum chemotherapy drug, is clinically employed to treat cancers especially for breast cancer and lung cancer. But its clinical applications are limited by the dose-dependent cardiac toxicity. Resveratrol (Res), a polyphenolic antitoxin, has been proved to b...
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Online 論文 テキスト |
| 言語: | English |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681569/ https://www.ncbi.nlm.nih.gov/pubmed/31534336 http://dx.doi.org/10.2147/IJN.S211130 |